Muscular Dystrophy Stocks List

Recent Signals

Date Stock Signal Type
2021-05-11 BNTC Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-11 BNTC Fell Below 200 DMA Bearish
2021-05-11 BNTC Fell Below 50 DMA Bearish
2021-05-11 DYN Bollinger Band Squeeze Range Contraction
2021-05-11 DYN Fell Below 20 DMA Bearish
2021-05-11 ELMD Bollinger Band Squeeze Range Contraction
2021-05-11 ELMD 20 DMA Support Bullish
2021-05-11 EWTX Doji - Bullish? Reversal
2021-05-11 FULC Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-11 FULC Lower Bollinger Band Walk Weakness
2021-05-11 LIFE Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-11 LIFE MACD Bullish Signal Line Cross Bullish
2021-05-11 PTCT New 52 Week Low Weakness
2021-05-11 SLDB Lower Bollinger Band Walk Weakness
2021-05-11 SMMT Doji - Bullish? Reversal
2021-05-11 SMMT MACD Bearish Centerline Cross Bearish
2021-05-11 SMMT NR7 Range Contraction
2021-05-11 SRPT New 52 Week Low Weakness
2021-05-11 TVTX Lower Bollinger Band Walk Weakness
2021-05-11 TVTX New Downtrend Bearish
2021-05-11 TVTX Calm After Storm Range Contraction
2021-05-11 WVE NR7 Range Contraction
2021-05-11 WVE 20 DMA Resistance Bearish
2021-05-11 WVE Bollinger Band Squeeze Range Contraction

Recent News for Muscular Dystrophy Stocks

Date Stock Title
May 12 LIFE aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, Achieve Milestones for First Year of Government Grant to Develop Bispecific Antibody Platform
May 12 SRPT Cathie Wood Loads Up $57M In Palantir As Stock Stages Reversal On Q1 Earnings Beat
May 11 ELMD Electromed EPS misses by $0.03, beats on revenue
May 11 ELMD Electromed, Inc. Announces Fiscal 2021 Third Quarter Financial Results
May 11 SMMT Summit Therapeutics: Whether It's A Go-Private Candidate
May 11 SLDB Solid Biosciences to Host First Quarter 2021 Financial Results and Business Update Call on May 14, 2021
May 11 LIFE aTyr Pharma Announces Promotion of Leslie Nangle, Ph.D., to Vice President of Research
May 11 SRPT 5 Growth Stocks Down 50% (or More) With Upside of 62% to 133%, According to Wall Street
May 11 ELMD Earnings Scheduled For May 11, 2021
May 11 SRPT Cathie Wood Cuts Apple Stake By 30% And Buys Coinbase, DraftKings
May 10 WVE Wave Life Sciences to Present at RBC Capital Markets Global Healthcare Virtual Conference
May 9 TVTX Travere Therapeutics, Inc. (TVTX) CEO Eric Dube on Q1 2021 Results - Earnings Call Transcript
May 9 WVE The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 9 LIFE The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 8 FULC Fulcrum Therapeutics, Inc. (FULC) CEO Bryan Stuart on Q1 2021 Results - Earnings Call Transcript
May 7 SRPT Here’s Why Artisan Partners Disposed its Sarepta Therapeutics Inc. (SRPT) Position
May 7 FULC Fulcrum Therapeutics to Present at the BofA Securities 2021 Virtual Health Care Conference
May 7 FULC A Look At Fulcrum Therapeutics' (NASDAQ:FULC) Share Price Returns
May 7 SRPT Cathie Wood Slashes Apple Stake To Half — Also Trims Google, Fastly: What You Need To Know
May 6 TVTX Travere Therapeutics EPS misses by $0.25, misses on revenue

Muscular dystrophy (MD) is a group of muscle diseases that results in increasing weakening and breakdown of skeletal muscles over time. The disorders differ in which muscles are primarily affected, the degree of weakness, how fast they worsen, and when symptoms begin. Many people will eventually become unable to walk. Some types are also associated with problems in other organs.The muscular dystrophy group contains thirty different genetic disorders that are usually classified into nine main categories or types. The most common type is Duchenne muscular dystrophy (DMD) which typically affects males beginning around the age of four. Other types include Becker muscular dystrophy, facioscapulohumeral muscular dystrophy, and myotonic dystrophy. They are due to mutations in genes that are involved in making muscle proteins. This can occur due to either inheriting the defect from one's parents or the mutation occurring during early development. Disorders may be X-linked recessive, autosomal recessive, or autosomal dominant. Diagnosis often involves blood tests and genetic testing.There is no cure for muscular dystrophy. Physical therapy, braces, and corrective surgery may help with some symptoms. Assisted ventilation may be required in those with weakness of breathing muscles. Medications used include steroids to slow muscle degeneration, anticonvulsants to control seizures and some muscle activity, and immunosuppressants to delay damage to dying muscle cells. Outcomes depend on the specific type of disorder.Duchenne muscular dystrophy, which represents about half of all cases of muscular dystrophy, affects about one in 5,000 males at birth. Muscular dystrophy was first described in the 1830s by Charles Bell. The word "dystrophy" is from the Greek dys, meaning "difficult" and troph meaning "nourish". Gene therapy, as a treatment, is in the early stages of study in humans.

More about Muscular Dystrophy
Browse All Tags